Myriam Benlaïfaoui

Statistics

Publications

Citations

601

H-Index

Active since

2020

Affiliations

Centre Hospitalier de l’Université de Montréal(Current)

Institut Gustave Roussy

McGill University

McGill University Health Centre

Inserm

Myriam Benlaïfaoui is an author at Centre Hospitalier de l’Université de Montréal specializing in host-microbiome interactions in cancer, oncology, and microbiome research.

Publications per year

2020–2025

Publications

The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer

Taiki Hakozaki, Corentin Richard, Arielle Elkrief et al. · Cancer Immunology Research · 2020 · 300 citations

Life Sciences, Microbiology, Oncology +17

A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota

Meriem Messaoudene, Reilly Pidgeon, Corentin Richard et al. · Cancer Discovery · 2022 · 227 citations · Full text

Medicine, Immunology, Oncology +17

<i>Helicobacter pylori</i> serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors

Marion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian et al. · OncoImmunology · 2022 · 29 citations · Full text

Life Sciences, Microbiology, Oncology +17

Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma

Cecilia Hes, Antoine Desîlets, Marion Tonneau et al. · Oral Oncology · 2023 · 17 citations · Full text

Life Sciences, Microbiology, Oncology +17

679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors

Corentin Richard, Myriam Benlaïfaoui, Omar El Ouarzadi et al. · Regular and Young Investigator Award Abstracts · 2020 · 15 citations · Full text

Agriculture, Nutrition, Oncology +17

1–5 of 6